The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

Gorlin Syndrome

Prevalence: 1/60000
oncologic

Basal cell carcinoma predisposition due to PTCH1 gene mutations.